1. Home
  2. Clinical Topics
  3. FDA warning for terbutaline in preterm labor
Clinical TopicsDrugs and DevicesNewsWeb ExclusivesWomen's Health

FDA warning for terbutaline in preterm labor

Share

The U.S. Food and Drug Administration issued a warning that terbutaline, indicated for asthma, bronchitis, and emphysema, should not be used in pregnant women for prevention or prolonged treatment of preterm labor because it can cause serious maternal heart problems and death. Oral terbutaline tablets should also not be used to the prevention or treatment of preterm labor. Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts